Navigation Links
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
Date:1/3/2012

p>TrovaGene has been building a franchise of proprietary markers in hematological oncology, including mutations in the nucleophosmin gene (NPM1), which are today widely used in the diagnosis of acute myeloid leukemia (AML), and the BRAF V600E mutation for diagnostic use in hairy cell leukemia (HCL).

"We believe that SF3B1 mutations have the potential to become key components of standard diagnostic panels with clinical utility in the management of patients suffering from CLL," states Antonius Schuh, TrovaGene's Chief Executive Officer. "We plan to offer laboratory-developed tests to detect SF3B1 mutations and to identify opportunities for the development of in-vitro diagnostic products incorporating our proprietary markers."

About TrovaGene, Inc.
Headquartered in San Diego, California, TrovaGene has focused on the development of its patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that cross the kidney barrier and can be detected in urine.

TrovaGene has a dominant patent position as relates to transrenal molecular testing. TrovaGene has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing. In addition, it owns worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myeloid leukemia (AML). TrovaGene has filed a Form 10 with the SEC. More complete current information about TrovaGene is contained in the filing.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on TrovaGene's current expectations and a
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
4. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
5. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
6. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
7. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
8. Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
9. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
10. China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief
11. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2014)... Phoenixville, PA (PRWEB) September 13, 2014 ... medical device innovations, is proud to announce the successful ... Health Network bariatric surgeons Leonardo Claros, MD, FACS, FAMBS, ... ViSiGi 3D™ Sleeve Gastrectomy Calibration System. , This ... a postgraduate course of more than four hundred surgeons ...
(Date:9/12/2014)... 12, 2014 Advancing the front ... of chemical and biological threats is the mission ... Polytechnic Institute (WPI) and the Georgian National Academy ... for Peace and Security Programme of the North ... Advanced Research Workshop series, the event is titled ...
(Date:9/12/2014)... 12, 2014 On Thursday, September 11, ... Dow Jones Industrial Average finished the day 0.12% lower at ... The gains were broad based as seven out of ten ... Care Sector Index ended the day at 741.83, down 0.33%, ... month. Investor-Edge has initiated coverage on the following equities: Exelixis ...
(Date:9/11/2014)... cells (hiPSCs), researchers have gained new insight into ... patterns of neuronal signaling associated with this disease. ... the hiPSCs of healthy individuals and of patients ... stem cells to release neurotransmitters, such as dopamine, ... linked to various disorders. By discovering a simple ...
Breaking Biology Technology:Boehringer Laboratories, Inc. Announces Live Surgery Using Innovative System to Calibrate Sleeve Gastrectomy 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Stem cells help researchers understand how schizophrenic brains function 2
... /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... in the manufacture,research, development, marketing and distribution ... a new bilingual corporate Web site under,the ... The new Web site was created ...
... of tightly packed nanostructures that resemble tiny nails, University ... have created a material that can repel almost any ... liquid on the surface slips past the heads of ... the surface completely. , The new material, which was ...
... Mass., Jan. 29 Thermo Fisher,Scientific Inc. (NYSE: ... it will present at the 2008 Merrill Lynch Global ... Grand Hyatt,Hotel in New York City. The company will ... Marijn E. Dekkers, president and chief executive officer ...
Cached Biology Technology:China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site 2Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2
(Date:9/15/2014)... released today by the National Academy of Sciences, ... and strategies for the program and will guide ... years (2015-2020). In addition, the program announced ... in 2015, will include exploratory grants, early-career research ... $500 million, 30-year program to be run by ...
(Date:9/15/2014)... in the oceans, there must be enough dissolved ... extreme oxygen-starvation produces "dead zones" that decimate marine ... oxygen levels decline, energy is increasingly diverted away ... in impacts on the ecology and biogeochemistry of ... oxygen minimum zones (OMZs) have expanded due to ...
(Date:9/15/2014)... who transplanted combinations of wild, domesticated, and ... to new environments found that within 5 ... foreign genes from wild populations that hybridized ... Applications study provides evidence that natural ... that hybridized populations experience as a result ...
Breaking Biology News(10 mins):NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4Decoding virus-host interactions in the oxygen-starved ocean 2Decoding virus-host interactions in the oxygen-starved ocean 3Decoding virus-host interactions in the oxygen-starved ocean 4Decoding virus-host interactions in the oxygen-starved ocean 5
... undergo surgery for breast cancer followed by radiation ... be corrected through reconstructive surgery. Researchers at the ... bioengineers at Carnegie Mellon University, have developed a ... as an artificial tissue filler after surgery and ...
... Researchers at the McKusick-Nathans Institute of Genetic Medicine at ... way of analyzing what many have termed "junk" DNA ... they have found that these control regions from different ... , The study will be published online at Science ...
... system response to foreign DNA, suggesting that DNA viruses ... School of Medicine researchers report this week in Immunity. ... be used to detect invasive bacteria in addition to ... in the Section of Immunobiology and lead author of ...
Cached Biology News:Chemotherapy gel may fight breast cancer and reduce breast deformity 2Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3Immune system response to viral DNA is unique 2
... Protein A and Protein G bind specifically ... Protein A and Protein G conjugates are ... immunoglobulins (antibodies) and immunoglobulin subtypes from serum, ... other biological fluids. These reagents are also ...
... The SYS203 is a complete, ... measurement in small samples, as is ... system is designed around Instechs miniature ... of an inch in diameter (3.2 ...
... family of human cullin genes (CUL-1, -2, -3, -4a, ... gene. Cullin-3 is proposed to be a part of ... cyclin E and targets it for ubiquitination, which leads ... activator of cdk2, which leads the cell to S ...
... MetaVue Imaging System is the cost-effective solution ... commands tailored to common research imaging tasks, ... analysis and simple image analysis. Compatibility ... library means that MetaVue has the power ...
Biology Products: